Obstetrics & Gynecology Doctors in Fort Riley, KS Accepting Medicare

7 Obstetrics & Gynecology doctors found. Showing 1 - 7

Dr. Julia Renee Gaston, M.D, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 650 Huebner Rd, Fort Riley, KS 66442 Phone: 785-239-7794    Fax: 785-239-7240

Jeffery Long, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 650 Huebner Rd, Ob/gyn, Fort Riley, KS 66442 Phone: 785-239-7028

Jarett Thomas Skinner, D.O. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 650 Huebner Rd, Irwin Army Community Hospital- General Surgery Clinic, Fort Riley, KS 66442 Phone: 785-473-6323

Dr. Heather Jinks, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 650 Huebner Rd, Fort Riley, KS 66442 Phone: 785-239-3627

Dr. Morgan Leigh Potter, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 650 Huebner Rd, Fort Riley, KS 66442 Phone: 785-239-7151    Fax: 785-240-7438

Dr. Daniel Cole Sessions, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 600 Caisson Hill Rd, Fort Riley, KS 66442 Phone: 785-239-7794

Dr. Mark S Ochoa, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 600 Caisson Hill Road, Fort Riley, KS 66442 Phone: 785-239-7794

News Archive

Scientists turn to old class of antibiotics to fight superbugs resistant to modern medicine

Scientists at the University at Buffalo are turning to an old class of antibiotics to fight new superbugs resistant to modern medicine.

High-dose flu vaccine more effective than standard dose for elders

If you're age 65 or older and go to your doctor or pharmacy for a flu shot, you may be offered two options: the standard vaccine, or a high-dose version that packs a stronger wallop to activate the immune system, which is weaker in seniors. The Centers for Disease Control and Prevention (CDC) says either vaccine is appropriate for this age group.

Inhibition of miR-24-3p may serve as potential treatment target for mesothelioma

Inhibition of miR-24-3p reduced growth of cancer cells and was found to regulate proteins as a potential treatment target for Mesothelioma.

Regeneron announces FDA approval of EYLEA Injection for DME treatment

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME).

Research findings may help combat MRSA

A research team from Vanderbilt University Medical Center in Nashville, Tenn., is the first to decipher the 3-D structure of a protein that confers antibiotic resistance from one of the most worrisome disease agents: a strain of bacteria called methicillin-resistant Staphylococcus aureus (MRSA), which can cause skin and other infections. The Vanderbilt team's findings may be an important step in combatting the MRSA public health threat over the next 5 to 10 years.

Read more Medical News

› Verified 3 days ago